• English
  • 简体中文
Login Register
Current Location: Home > CFDA Approvals(Import) Feedback Help Print
Registration No. 国药准字SJ20140005
Original Registration No. S20140005
Drug Name(Chinese) 甘精胰岛素注射液
Drug Name(English) Insulin Glargine Injection
Proprietary Name(Chinese) 来得时
Proprietary Name(English) 暂无权限
Drug Sandard Code(Chines) 86978820000596
Manufacturers(English) Sanofi-Aventis Deutschland GmbH
Production Address(English) Industriepark Hoechst,Brueningstrasse 50,D-65926 Frankfurt am Main, Germany
State(Chinese) 德国
State(English) Germany
Dosage Form 注射剂
Strength 3ml:300单位/笔芯/预填充SoloStar
Packaging 5支/盒(笔芯/预填充),1支/盒(笔芯/预填充)
Date Issued 2023-07-24
Valid Until 2028-07-23
Category 生物制品